Table 1.
Characteristics | Colorectal cancer survivors no. (%) | References no. (%) |
---|---|---|
All | 6679 (100) | 26,716 (100) |
Sex | ||
Men | 3598 (53.9) | 14,392 (53.9) |
Women | 3081 (46.1) | 12,324 (46.1) |
Age, years | ||
18–50 | 1783 (26.7) | 7132 (26.7) |
51–55 | 1319 (19.8) | 5276 (19.8) |
56–60 | 2271 (34.0) | 9084 (34.0) |
61–62 | 1306 (19.6) | 5224 (19.6) |
Country of birth | ||
Sweden | 5624 (84.2) | 22,496 (84.2) |
other | 1055 (15.8) | 4220 (15.8) |
Educational level (years) | ||
Elementary school (<10) | 1467 (22.0) | 5868 (22.0) |
High school (10-12) | 3120 (46.7) | 12,480 (46.7) |
University/college (>12) | 2092 (31.3) | 8368 (31.3) |
Cancer type | ||
Colon cancer | 4044 (60.6) | - |
Rectal cancer | 2635 (39.5) | - |
Cancer stage | ||
Stage 0 + I | 2109 (31.6) | - |
Stage II | 1270 (19.0) | - |
Stage III | 1464 (21.9) | - |
Stage IV | 1203 (18.0) | - |
Missing | 633 (9.5) | - |
Charlson Comorbidity Indexa in the 3 years prior to diagnosis date (Y-3 – Y-1) | ||
0+1 | 5505 (82.4) | 25,588 (95.8) |
≥2 | 1174 (17.6) | 1128 (4.2) |
Mental morbidity in the 3 years prior to diagnosis date (Y-3 – Y-1) | ||
None | 5424 (81.2) | 22,317 (83.5) |
Any | 1255 (18.8) | 4399 (16.5) |
aCharlson Comorbidity Index was calculated based on all diagnoses from specialized healthcare within the 3 years before diagnosis date